AI Verdict
RMAX has stronger fundamentals based on our AI analysis.
RMAX vs RLMD Fundamental Comparison
| Metric | RMAX | RLMD |
|---|---|---|
| Revenue | $291.6M | $5.2M |
| Net Income | $8.2M | $-57.4M |
| Net Margin | 2.8% | -1,113.9% |
| ROE | 1.8% | -66.3% |
| ROA | 1.4% | -61.0% |
| Current Ratio | 1.69x | 14.62x |
| Debt/Equity | 0.96x | 0.00x |
| EPS | $0.60 | $-1.45 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RMAX vs RLMD: Frequently Asked Questions
Is RMAX or RLMD a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RMAX has stronger fundamentals. RMAX is rated SELL (72% confidence) while RLMD is rated STRONG SELL (78% confidence). This is not investment advice.
How does RMAX compare to RLMD fundamentally?
RE/MAX Holdings, Inc. has ROE of 1.8% vs RELMADA THERAPEUTICS, INC.'s -66.3%. Net margins are 2.8% vs -1,113.9% respectively.
Which stock pays higher dividends, RMAX or RLMD?
RMAX has a dividend yield of N/A or no dividend while RLMD has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RMAX or RLMD for long term?
For long-term investing, consider that RMAX has SELL rating with 72% confidence, while RLMD has STRONG SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RMAX vs RLMD?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RMAX vs RLMD, the AI consensus favors RMAX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.